Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 28, 2021 09:00 ET | Source: Rénibus Therapeutics Inc.

Renibus Therapeutics Announces Presentations at the American Society of Nephrology Kidney Week 2021

DALLAS, Texas, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Renibus Therapeutics, Inc., a clinical-stage biotechnology company, announced today that it will present abstracts at the American Society of...
October 19, 2020 09:00 ET | Source: Rénibus Therapeutics Inc.

Renibus Therapeutics Announces Presentations at the American Society of Nephrology Kidney Week 2020

DALLAS, Texas, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Renibus Therapeutics, Inc., a clinical-stage biotechnology company, announced today that it will present five abstracts at the American Society of...
October 07, 2020 09:00 ET | Source: Rénibus Therapeutics Inc.

Renibus Therapeutics’ COVID-19 Treatment, RBT-9, Shows Antiviral Activity Against SARS-CoV-2 In Vitro

DALLAS, Texas, Oct. 07, 2020 (GLOBE NEWSWIRE) -- Renibus Therapeutics, Inc., a clinical-stage biotechnology company, announced today that its investigational treatment for COVID-19, RBT-9, has...
June 23, 2020 09:00 ET | Source: Rénibus Therapeutics Inc.

Renibus Therapeutics Receives FDA Fast Track Designation for RBT-9 Treatment in COVID-19

DALLAS, Texas, June 23, 2020 (GLOBE NEWSWIRE) -- Renibus Therapeutics, Inc., a clinical-stage biotechnology company, announced today that it has been granted Fast Track designation by the FDA for...